dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Martinez-Useros, Javier |
dc.contributor.author | Georgiev-Hristov, Tihomir |
dc.contributor.author | Fernández-Aceñero, María Jesús |
dc.contributor.author | Borrero-Palacios, Áurea |
dc.contributor.author | Guerrero, Santiago |
dc.contributor.author | Indacochea Cusirramos, Alberto |
dc.date.accessioned | 2021-05-04T12:14:40Z |
dc.date.available | 2021-05-04T12:14:40Z |
dc.date.issued | 2017-08-01 |
dc.identifier.citation | Martinez-Useros J, Georgiev-Hristov T, Fernández-Aceñero MJ, Borrero-Palacios A, Indacochea A, Guerrero S, et al. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept. Fernandez-Zapico M, editor. PLoS One. 2017 Aug 1;12(8):e0182044. |
dc.identifier.issn | 1932-6203 |
dc.identifier.uri | https://hdl.handle.net/11351/5938 |
dc.description | Tractament del càncer; Expressió gènica; Anàlisi de supervivència |
dc.description.sponsorship | This work has been carried out with the support of the RNA-Reg CONSOLIDER Network CSD2009-00080 (J.M.-U. and J.G.-F.), and Spanish Health Research Project Funds PI16/01468 from “Instituto de Salud Carlos III” (A.C. and J.G.-F.), both of the Spanish Ministry of Economy, Industry and Competitiveness. |
dc.language.iso | eng |
dc.publisher | Public Library of Science |
dc.relation.ispartofseries | PLoS ONE;12(8) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Tumors |
dc.subject | Càncer - Cirurgia |
dc.subject | Supervivència |
dc.subject.mesh | Progression-Free Survival |
dc.subject.mesh | Carcinoma, Pancreatic Ductal |
dc.subject.mesh | /surgery |
dc.title | UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1371/journal.pone.0182044 |
dc.subject.decs | supervivencia libre de progresión |
dc.subject.decs | carcinoma ductal pancreático |
dc.subject.decs | /cirugía |
dc.relation.publishversion | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182044 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Martinez-Useros J, Borrero-Palacios A] Translational Oncology Division, OncoHealth Institute, University Hospital Fundacion Jimenez Diaz (FJD), Madrid, Spain. [Georgiev-Hristov T] Surgery Department, Hospital de Villalba, Collado-Villalba, Spain. [Fernández-Aceñero MJ] Department of Pathology, Clinico San Carlos University Hospital, C/ Profesor Martin Lagos, Madrid, Spain. [Indacochea A] Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain. Oncology and Molecular Pathology Research Group, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Guerrero S] Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain. Universitat Pompeu Fabra (UPF), Barcelona, Spain |
dc.identifier.pmid | 28763470 |
dc.identifier.wos | 000406766500036 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01468 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |